Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

COGT

Cogent Biosciences, Inc.

Healthcare · USD

Set alert

Price alert · COGT

All alert types
31.02 USD -0.94 -2.94%
As of Oct 30, 2026 Extended hours 31.30 +0.90%
Bid
31.00 × 2
Ask
31.02 × 2
30.65 Day range 32.34
14.13 52-week range 42.84
YTD
-12.67%
1 year
+91.36%
Open
31.75
Prev close
31.96
Mkt cap
5.38B
Vol
2.50M
Avg vol
1.99M
EPS
-2.16
P/E
0.00
Div yield
0.00%
More statistics
Low
30.65
High
32.34
Forward P/E
-25.92
Beta
0.31
Short ratio
8.48
Inst. own
115.68%
Dividend
0.00
Ex-div date
Earnings
Nov 6, 2026
50-d avg
32.51
200-d avg
35.74
1y target
55.82

5D chart

Chart tools
Interval
1m5m15m30m
COGT five-day price chart30.531.131.732.332.9Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

7.95 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -17.4×
FY 2016: -14.3×FY 2017: -12.9×FY 2018: -3.2×FY 2019: -0.7×FY 2020: -1.9×FY 2021: -4.6×FY 2022: -5.1×FY 2023: -2.4×FY 2024: -3.4×FY 2025: -17.4×
FY 2016 5y median -4.6× FY 2025
P/S 0.0×
FY 2016: 40.9×FY 2017: 39.3×FY 2018: 11.3×FY 2019: 1.0×FY 2020: 15.8×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 9.0×
FY 2016: 5.0×FY 2017: 11.6×FY 2018: 1.8×FY 2019: 0.7×FY 2020: 0.5×FY 2021: 1.6×FY 2022: 2.7×FY 2023: 1.8×FY 2024: 3.4×FY 2025: 9.0×
FY 2016 5y median 2.7× FY 2025
P/FCF -21.5×
FY 2016: -11.9×FY 2017: -12.3×FY 2018: -3.3×FY 2019: -0.5×FY 2020: -3.5×FY 2021: -5.5×FY 2022: -5.4×FY 2023: -3.0×FY 2024: -4.1×FY 2025: -21.5×
FY 2016 5y median -5.4× FY 2025
EV/EBITDA -17.6×
FY 2016: -12.0×FY 2017: -12.0×FY 2018: -1.6×FY 2019: 0.3×FY 2020: 3.3×FY 2021: -1.6×FY 2022: -4.3×FY 2023: -2.3×FY 2024: -3.1×FY 2025: -17.6×
FY 2016 5y median -3.1× FY 2025
EV/Sales 0.0×
FY 2016: 34.4×FY 2017: 35.9×FY 2018: 5.5×FY 2019: -0.4×FY 2020: -14.3×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -4.7%
FY 2016: -8.4%FY 2017: -8.1%FY 2018: -30.2%FY 2019: -189.3%FY 2020: -28.8%FY 2021: -18.2%FY 2022: -18.5%FY 2023: -33.4%FY 2024: -24.2%FY 2025: -4.7%
FY 2016 5y median -18.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 99.8%FY 2020: -227.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -300.1%FY 2017: -312.8%FY 2018: -369.9%FY 2019: -143.0%FY 2020: -1044.3%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -285.2%FY 2017: -304.9%FY 2018: -354.8%FY 2019: -134.6%FY 2020: -950.4%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -51.7%
FY 2016: -34.6%FY 2017: -90.1%FY 2018: -57.3%FY 2019: -95.3%FY 2020: -31.9%FY 2021: -33.7%FY 2022: -54.8%FY 2023: -74.6%FY 2024: -99.8%FY 2025: -51.7%
FY 2016 5y median -54.8% FY 2025
ROIC -38.1%
FY 2016: -28.5%FY 2017: -69.0%FY 2018: -59.0%FY 2019: -85.1%FY 2020: -34.3%FY 2021: -34.8%FY 2022: -53.7%FY 2023: -75.2%FY 2024: -100.8%FY 2025: -38.1%
FY 2016 5y median -53.7% FY 2025
ROA -35.1%
FY 2016: -24.0%FY 2017: -51.9%FY 2018: -40.2%FY 2019: -61.3%FY 2020: -29.8%FY 2021: -31.1%FY 2022: -46.6%FY 2023: -61.4%FY 2024: -78.0%FY 2025: -35.1%
FY 2016 5y median -46.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 112.8%FY 2017: 31.5%FY 2018: 16.4%FY 2019: 131.1%FY 2020: -65.0%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -20.8%
FY 2016: -189.3%FY 2017: -37.1%FY 2018: -37.7%FY 2019: 10.6%FY 2020: -155.5%FY 2021: 8.1%FY 2022: -95.7%FY 2023: -40.8%FY 2024: -32.6%FY 2025: -20.8%
FY 2016 FY 2025
EPS (diluted) 12.1%
FY 2016: -175.3%FY 2017: -40.8%FY 2018: -60.9%FY 2019: 28.5%FY 2020: -51.1%FY 2021: 69.2%FY 2022: -22.2%FY 2023: -7.1%FY 2024: 4.1%FY 2025: 12.1%
FY 2016 FY 2025
Free Cash Flow -27.7%
FY 2016: -239.6%FY 2017: -21.9%FY 2018: -23.5%FY 2019: -25.8%FY 2020: 13.7%FY 2021: -68.7%FY 2022: -107.5%FY 2023: -24.6%FY 2024: -33.2%FY 2025: -27.7%
FY 2016 FY 2025

Financial Health

Current Ratio 14.2×
FY 2016: 8.0×FY 2017: 3.8×FY 2018: 3.2×FY 2019: 3.1×FY 2020: 18.7×FY 2021: 13.0×FY 2022: 9.9×FY 2023: 7.1×FY 2024: 5.3×FY 2025: 14.2×
FY 2016 5y median 9.9× FY 2025
Quick Ratio 14.2×
FY 2016: 8.0×FY 2017: 3.8×FY 2018: 3.2×FY 2019: 3.1×FY 2020: 18.7×FY 2021: 13.0×FY 2022: 9.9×FY 2023: 7.1×FY 2024: 5.3×FY 2025: 14.2×
FY 2016 5y median 9.9× FY 2025
Debt / Equity 0.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.4×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 2.3×FY 2017: 1.1×FY 2018: 1.6×FY 2019: 1.0×FY 2020: 6.9×FY 2021: 3.0×FY 2022: 0.9×FY 2023: 0.2×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -109×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -37.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -109×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31